Fat-loss isn’t just a buzzword; it’s the holy grail in the world of metabolism, weight-management, and wellness. Especially when it comes attached to an intriguing peptide like AOD9604, the curiosity meter goes off the charts. Here at Oath Research, the question is on everyone’s lips: Can fat-loss actually improve non-anabolic metabolism, or is it just exciting science-speak for researchers and wellness nerds?
Please note: AOD9604 is sold strictly for in vitro research and laboratory use only. It is not intended for human or animal consumption.
Cracking the Code: What Makes AOD9604 So Special for Fat-Loss?
Let’s dive right into the science. AOD9604 is not your average member of the peptide family. It’s actually a synthesized fragment of human growth hormone, corresponding to the C-terminal region (amino acids 176-191) with a tyrosine substitution at the N-terminus. But before you start picturing bodybuilders and Herculean biceps, hold your horses! AOD9604 is a non-anabolic peptide, which is a fancy way of saying it doesn’t build muscle mass or push your ribcage out three shirt sizes.
Instead, it zeroes in on fat metabolism, working through lipolysis—the breakdown of pesky fat stores—and, even more fascinatingly, it achieves all this without the side effects seen with anabolic agents. Early metabolic studies demonstrated that AOD9604 reduced body weight gain by over 50% in obese rat models while preserving insulin sensitivity, unlike full-length hGH which can impair glucose tolerance (Ng et al., 2000). If you’re hunting for optimized weight-management research without the muscle-building drama, this is your prime suspect.
AOD9604 and Non-Anabolic Metabolism: The Fat-Loss Promise
Here’s the punchline: fat-loss through non-anabolic means isn’t just theoretical. The brilliance of AOD9604 lies in its direct action on fat cells, spurring them to release their energy payload through increased lipolysis. That means your metabolism gets a jolt—the kind that sends a memo to your body: “Hey! Let’s burn the fuel tank (aka fat) instead of hoarding it for a faux famine.”
Unlike classic hGH peptides, which stimulate IGF-1 and trigger both muscle growth and fat breakdown, AOD9604 works independently of these anabolic pathways. In a pivotal 2001 study, Heffernan et al. showed that both hGH and AOD9604 significantly reduced body weight gain in obese mice through increased in vivo fat oxidation and elevated plasma glycerol levels—an index of lipolysis. Critically, unlike hGH, AOD9604 did not induce hyperglycemia or reduce insulin secretion (Heffernan et al., 2001).
Lipolysis—the enzymatic breakdown of stored triglycerides into free fatty acids and glycerol—is the core process AOD9604 targets. According to peer-reviewed research, AOD9604 amplifies the rate at which triglycerides break down in adipose tissue, releasing fatty acids to be used for energy.
What makes this unique? Remember: AOD9604 is non-anabolic. If your research focus is metabolism without the unwanted bulking effects, this peptide lets you zoom in on fat-loss as a standalone metric. A follow-up study by the same Monash University group demonstrated that AOD9604’s lipolytic action occurs independently of beta-3 adrenergic receptors, suggesting a distinct mechanism from conventional lipolytic agents (Heffernan et al., 2001).
– Direct action on adipose tissue (translation: fat cells take the hit)
– Minimal to no effect on lean muscle mass
– Bonus: No major impact on glucose regulation or hormone balance
In short, AOD9604 targets fat cells with precision while leaving your muscles and sugar-controls unbothered. All research discussed here is from preclinical and in vitro studies. AOD9604 is intended for research purposes only.
Weight-Management Game-Changer: Non-Anabolic Fat-Loss in Research
So, where does AOD9604 fit into the grand scheme of weight-management? Picture it as a scalpel, not a sledgehammer. This peptide allows scientific minds to tease out the difference between “burning fat” and “building muscle.” By harnessing targeted fat-loss without the usual anabolic baggage, it opens up exciting doors for researchers looking to:
– Model non-anabolic weight-management interventions
– Investigate safer metabolic modulation strategies
– Explore synergy with other non-anabolic compounds
If your research project wants to compare agents for weight-management with a keen eye on safety, minimal hormonal disruption, and maximum precision—AOD9604 makes a robust addition to the peptide toolkit. For those fascinated by where fat-loss ends and non-anabolic metabolism begins, it offers a unique separation of church and state.
Curious to see the peptide itself? Check out our AOD9604 research-grade peptide at OathPeptides.com. Remember: All products are strictly for research purposes and not for human or animal use.
AOD9604 vs Classic hGH Fragment: Who Wins at Fat-Loss?
You might be thinking, “If both AOD9604 and hGH-fragment 176-191 are born from the same mother peptide, which is the real fat-loss MVP?” Here’s where things get spicy.
Both peptides light the lipolytic fuse, but AOD9604 is designed for improved stability and focused action in scientific models. While classic hGH fragments may support metabolism through a more generalized receptor profile, AOD9604’s structure targets adipose tissue with greater precision. Importantly, AOD9604 does not compete for the hGH receptor and does not induce cell proliferation, unlike full-length hGH—a significant advantage for researchers seeking clean lipolytic data.
Check out our hGH Fragment 176-191 for comparative research at OathPeptides.com.
The Metabolic Impact: Can Fat-Loss Alone Improve Overall Health?
Great question! Let’s clarify: In a purely non-anabolic context, enhanced lipolysis and targeted fat-loss can translate to improvements in markers of metabolic health—at least in controlled research models. While fat-loss from AOD9604 may not directly increase lean mass, it could mean:
However, a crucial note: true human research is required to substantiate these effects outside the laboratory setting. As always, our products are for research only, not for human use.
Beyond Fat-Loss: AOD9604 and Cartilage Research
An emerging area of AOD9604 research involves joint health. A 2015 study by Kwon and Park demonstrated that intra-articular AOD9604 injections enhanced cartilage regeneration in a rabbit osteoarthritis model, and the combination of AOD9604 with hyaluronic acid was more effective than either treatment alone (Kwon & Park, 2015). A 2024 review in Cartilage included AOD9604 among peptides currently being investigated for chondrogenic induction and cartilage regeneration in osteoarthritis research (Liao et al., 2024). This dual potential—fat metabolism and joint health—makes AOD9604 an increasingly versatile compound for laboratory investigation.
Fat-Loss and Non-Anabolic Synergy: More Than the Sum of Its Parts?
Is it possible to design weight-management protocols featuring more than one peptide? Absolutely! For example, pairing AOD9604 with non-anabolic mitochondria modulators like MOTS-c or with hunger-modulating research peptides like Cagrilintide allows you to tweak metabolism and feeding behavior, all without breaking the anabolic barrier.
Combining these opens up new frontiers for non-anabolic fat-loss and metabolism research. All compounds mentioned are for research purposes only and are not approved for human or animal use.
Safety First: Non-Anabolic, Minimum Side Effects
What really sets AOD9604 apart? Its well-documented safety profile. Across six randomized, double-blind, placebo-controlled clinical studies involving approximately 900 participants, AOD9604 demonstrated a safety and tolerability profile indistinguishable from placebo, with no effect on serum IGF-1 levels, glucose tolerance, or immunogenicity (Stier et al., 2013).
Serious scientists love peptides that don’t interfere where they’re not invited. By working outside the major anabolic pathways, AOD9604 has shown promising results for fat-loss intervention studies—especially for those wary of the risks linked to classic growth hormone use. Further non-clinical studies revealed no evidence of genotoxicological or toxicological concerns (More & Kenley, 2014).
Deep Dive: AOD9604, Lipolysis & Optimized Weight-Management
Ready to jump feet-first into the nitty-gritty? Here’s a breakdown of how AOD9604 could fit into non-anabolic fat-loss research:
1. Mechanism Overview:
Derived from the C-terminal sequence of hGH, AOD9604 mimics the fat-reducing action of growth hormone but skips the muscle-building scene. Its folding and structure ensure targeted receptor activation linked to lipolysis.
2. Weight Loss in Preclinical Models:
Studies in animal models reveal meaningful reductions in fat mass, with little or no effect on lean body mass. Researchers observed improvement in fat percentage, particularly with chronic administration. In one study, chronic treatment with AOD9604 increased fat oxidation rates significantly compared to saline controls (Heffernan et al., 2001).
3. Metabolic Markers:
Some evidence links AOD9604 research to improved insulin sensitivity, reduced blood triglycerides, and anti-inflammatory phenomena, although results are preliminary and need extensive validation.
4. Comparison with Other Peptides:
Unlike anabolic agents like CJC-1295 or GHRP-2, AOD9604 brings the heat to the fat-loss party without crowding the muscle-building dance floor. If your research pivots on non-anabolic weight-management, this is the peptide to watch.
Curious how these stack up? Explore CJC-1295 or GHRP-2 for a robust comparison. But don’t forget: All our products are for research use only.
FAQ: Burning Questions on AOD9604, Fat-Loss & Non-Anabolic Metabolism
1. What is AOD9604, and how is it different from regular hGH fragments?
AOD9604 is a synthetic fragment (176-191) of human growth hormone, optimized for fat-loss through targeted lipolysis, without the muscle-building effects or hormonal impacts of full hGH peptides.
2. Does AOD9604 promote muscle growth?
No. It’s strictly non-anabolic. It zeroes in on fat metabolism and weight-management with no direct impact on lean muscle.
3. What’s the mechanism of action for AOD9604 in research models?
AOD9604 enhances lipolysis in adipose tissue by mimicking certain fat-burning actions of hGH but does not activate the broader anabolic or IGF-1 pathways.
4. Can AOD9604 improve other markers of metabolism besides fat-loss?
Studies suggest potential benefits for insulin sensitivity and lipid profiles, but these findings are still in early research stages.
5. How does AOD9604 compare to traditional fat-loss agents?
Unlike stimulants or appetite suppressants, AOD9604 works directly on fat tissue with minimal central side effects, offering a targeted, non-anabolic approach.
6. Are there any surprising side effects?
In human safety trials involving approximately 900 subjects, AOD9604 showed a tolerability profile indistinguishable from placebo. Of course, all products are not for use in humans or animals—strictly research only.
7. What makes AOD9604 a promising tool for metabolic research?
Its focused action on fat tissue, non-anabolic profile, and minimal systemic effects create a unique research niche.
8. Can AOD9604 be stacked with other research peptides?
Absolutely—pairing with compounds that influence other aspects of metabolism can help researchers model multi-pronged weight-management strategies.
9. Where do I find AOD9604 for research?
We offer AOD9604 for research purposes only here at OathPeptides.com.
10. What are the main benefits for experimental weight-management?
Precision fat-loss, study of non-anabolic metabolism, and lack of hormonal disruption are key perks.
11. Is there human data on AOD9604?
Yes—early-phase clinical trial data across six placebo-controlled studies exists, demonstrating safety and tolerability. However, the peptide has not been approved for human or animal use. All findings should be interpreted strictly in a research context.
Wrapping It Up: The Future of Fat-Loss and Non-Anabolic Metabolism
In the wild world of metabolism research, AOD9604 is generating serious buzz. Its unique focus on fat-loss, targeted lipolysis, and non-anabolic profile sets it apart from traditional peptides and promises new insights for metabolic science and weight-management.
Curious to join the next wave of discovery? Grab AOD9604 and other high-purity peptides (like hGH Fragment 176-191) for your next research project at OathPeptides.com. Remember, every product is for research use only—please do not use it in humans or animals.
1. Ng FM, Sun J, Sharma L, Libinaka R, Jiang WJ, Gianello R. “Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.” Hormone Research. 2000;53(6):274-278. PubMed
2. Heffernan MA, Thorburn AW, Fam B, Summers R, Conway-Campbell B, Waters MJ, Ng FM. “Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.” International Journal of Obesity. 2001;25(10):1442-1449. PubMed
3. Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM. “The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.” Endocrinology. 2001;142(12):5182-5189. PubMed
4. Stier H, Vos E, Kenley D. “Safety and tolerability of the hexadecapeptide AOD9604 in humans.” Journal of Endocrinology and Metabolism. 2013;3(1-2):7-15. Full Text
5. More MI, Kenley D. “Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health.” Journal of Endocrinology and Metabolism. 2014;4(3):59-69. Full Text
6. Kwon DR, Park GY. “Effect of intra-articular injection of AOD9604 with or without hyaluronic acid in rabbit osteoarthritis model.” Annals of Clinical and Laboratory Science. 2015;45(4):426-432. PubMed
7. Liao HJ, Chen HT, Chang CH. “Peptides for targeting chondrogenic induction and cartilage regeneration in osteoarthritis.” Cartilage. 2024;15(3):303-318. PubMed
All statements herein refer to laboratory research, not clinical or personal use. Oath Research peptides are sold strictly for research—never for human or animal use.
Curious about getting that bronzed look without basking in the sun? Melanotan I, a tanning peptide making waves in research circles, promises a stunning tan— but does this shortcut to sun-kissed skin come with hidden risks?
D‑peptides stand out for their exclusive protease resistance, giving them unmatched stability that keeps them intact and effective longer than natural peptides. This unique trait makes D‑peptides a game-changer in research and therapeutic fields where durability is key.
Selank and Semax, synthetic heptapeptides derived from tuftsin and ACTH(4-10) respectively, modulate BDNF expression through distinct yet overlapping neurotrophic signaling cascades. This review compares their preclinical pharmacology, gene expression profiles, and receptor interactions in rodent models.
Curious about whether your gh-secretagogue stack could be holding back gh-pulse recovery or lean-mass gains? Dive in as we unravel how synergy—both good and bad—might influence your stacking strategies in the pursuit of optimal research outcomes.
AOD9604 Peptide: Can Fat-Loss Improve Non-Anabolic Metabolism?
Fat-loss isn’t just a buzzword; it’s the holy grail in the world of metabolism, weight-management, and wellness. Especially when it comes attached to an intriguing peptide like AOD9604, the curiosity meter goes off the charts. Here at Oath Research, the question is on everyone’s lips: Can fat-loss actually improve non-anabolic metabolism, or is it just exciting science-speak for researchers and wellness nerds?
Please note: AOD9604 is sold strictly for in vitro research and laboratory use only. It is not intended for human or animal consumption.
Cracking the Code: What Makes AOD9604 So Special for Fat-Loss?
Let’s dive right into the science. AOD9604 is not your average member of the peptide family. It’s actually a synthesized fragment of human growth hormone, corresponding to the C-terminal region (amino acids 176-191) with a tyrosine substitution at the N-terminus. But before you start picturing bodybuilders and Herculean biceps, hold your horses! AOD9604 is a non-anabolic peptide, which is a fancy way of saying it doesn’t build muscle mass or push your ribcage out three shirt sizes.
Instead, it zeroes in on fat metabolism, working through lipolysis—the breakdown of pesky fat stores—and, even more fascinatingly, it achieves all this without the side effects seen with anabolic agents. Early metabolic studies demonstrated that AOD9604 reduced body weight gain by over 50% in obese rat models while preserving insulin sensitivity, unlike full-length hGH which can impair glucose tolerance (Ng et al., 2000). If you’re hunting for optimized weight-management research without the muscle-building drama, this is your prime suspect.
AOD9604 and Non-Anabolic Metabolism: The Fat-Loss Promise
Here’s the punchline: fat-loss through non-anabolic means isn’t just theoretical. The brilliance of AOD9604 lies in its direct action on fat cells, spurring them to release their energy payload through increased lipolysis. That means your metabolism gets a jolt—the kind that sends a memo to your body: “Hey! Let’s burn the fuel tank (aka fat) instead of hoarding it for a faux famine.”
Unlike classic hGH peptides, which stimulate IGF-1 and trigger both muscle growth and fat breakdown, AOD9604 works independently of these anabolic pathways. In a pivotal 2001 study, Heffernan et al. showed that both hGH and AOD9604 significantly reduced body weight gain in obese mice through increased in vivo fat oxidation and elevated plasma glycerol levels—an index of lipolysis. Critically, unlike hGH, AOD9604 did not induce hyperglycemia or reduce insulin secretion (Heffernan et al., 2001).
Lipolysis Unleashed: Science Behind AOD9604’s Mechanism
Lipolysis—the enzymatic breakdown of stored triglycerides into free fatty acids and glycerol—is the core process AOD9604 targets. According to peer-reviewed research, AOD9604 amplifies the rate at which triglycerides break down in adipose tissue, releasing fatty acids to be used for energy.
What makes this unique? Remember: AOD9604 is non-anabolic. If your research focus is metabolism without the unwanted bulking effects, this peptide lets you zoom in on fat-loss as a standalone metric. A follow-up study by the same Monash University group demonstrated that AOD9604’s lipolytic action occurs independently of beta-3 adrenergic receptors, suggesting a distinct mechanism from conventional lipolytic agents (Heffernan et al., 2001).
– Direct action on adipose tissue (translation: fat cells take the hit)
– Minimal to no effect on lean muscle mass
– Bonus: No major impact on glucose regulation or hormone balance
In short, AOD9604 targets fat cells with precision while leaving your muscles and sugar-controls unbothered. All research discussed here is from preclinical and in vitro studies. AOD9604 is intended for research purposes only.
Weight-Management Game-Changer: Non-Anabolic Fat-Loss in Research
So, where does AOD9604 fit into the grand scheme of weight-management? Picture it as a scalpel, not a sledgehammer. This peptide allows scientific minds to tease out the difference between “burning fat” and “building muscle.” By harnessing targeted fat-loss without the usual anabolic baggage, it opens up exciting doors for researchers looking to:
– Model non-anabolic weight-management interventions
– Investigate safer metabolic modulation strategies
– Explore synergy with other non-anabolic compounds
If your research project wants to compare agents for weight-management with a keen eye on safety, minimal hormonal disruption, and maximum precision—AOD9604 makes a robust addition to the peptide toolkit. For those fascinated by where fat-loss ends and non-anabolic metabolism begins, it offers a unique separation of church and state.
Curious to see the peptide itself? Check out our AOD9604 research-grade peptide at OathPeptides.com. Remember: All products are strictly for research purposes and not for human or animal use.
$99.99Original price was: $99.99.$95.00Current price is: $95.00.AOD9604 vs Classic hGH Fragment: Who Wins at Fat-Loss?
You might be thinking, “If both AOD9604 and hGH-fragment 176-191 are born from the same mother peptide, which is the real fat-loss MVP?” Here’s where things get spicy.
Both peptides light the lipolytic fuse, but AOD9604 is designed for improved stability and focused action in scientific models. While classic hGH fragments may support metabolism through a more generalized receptor profile, AOD9604’s structure targets adipose tissue with greater precision. Importantly, AOD9604 does not compete for the hGH receptor and does not induce cell proliferation, unlike full-length hGH—a significant advantage for researchers seeking clean lipolytic data.
Check out our hGH Fragment 176-191 for comparative research at OathPeptides.com.
The Metabolic Impact: Can Fat-Loss Alone Improve Overall Health?
Great question! Let’s clarify: In a purely non-anabolic context, enhanced lipolysis and targeted fat-loss can translate to improvements in markers of metabolic health—at least in controlled research models. While fat-loss from AOD9604 may not directly increase lean mass, it could mean:
– Healthier lipid profiles
– Reduced inflammation
– Enhanced mitochondrial function (read: better cellular energy)
However, a crucial note: true human research is required to substantiate these effects outside the laboratory setting. As always, our products are for research only, not for human use.
Beyond Fat-Loss: AOD9604 and Cartilage Research
An emerging area of AOD9604 research involves joint health. A 2015 study by Kwon and Park demonstrated that intra-articular AOD9604 injections enhanced cartilage regeneration in a rabbit osteoarthritis model, and the combination of AOD9604 with hyaluronic acid was more effective than either treatment alone (Kwon & Park, 2015). A 2024 review in Cartilage included AOD9604 among peptides currently being investigated for chondrogenic induction and cartilage regeneration in osteoarthritis research (Liao et al., 2024). This dual potential—fat metabolism and joint health—makes AOD9604 an increasingly versatile compound for laboratory investigation.
Fat-Loss and Non-Anabolic Synergy: More Than the Sum of Its Parts?
Is it possible to design weight-management protocols featuring more than one peptide? Absolutely! For example, pairing AOD9604 with non-anabolic mitochondria modulators like MOTS-c or with hunger-modulating research peptides like Cagrilintide allows you to tweak metabolism and feeding behavior, all without breaking the anabolic barrier.
Check out:
– MOTS-c Peptide
– Cagrilintide Research Compound
Combining these opens up new frontiers for non-anabolic fat-loss and metabolism research. All compounds mentioned are for research purposes only and are not approved for human or animal use.
Safety First: Non-Anabolic, Minimum Side Effects
What really sets AOD9604 apart? Its well-documented safety profile. Across six randomized, double-blind, placebo-controlled clinical studies involving approximately 900 participants, AOD9604 demonstrated a safety and tolerability profile indistinguishable from placebo, with no effect on serum IGF-1 levels, glucose tolerance, or immunogenicity (Stier et al., 2013).
Serious scientists love peptides that don’t interfere where they’re not invited. By working outside the major anabolic pathways, AOD9604 has shown promising results for fat-loss intervention studies—especially for those wary of the risks linked to classic growth hormone use. Further non-clinical studies revealed no evidence of genotoxicological or toxicological concerns (More & Kenley, 2014).
$99.99Original price was: $99.99.$95.00Current price is: $95.00.Deep Dive: AOD9604, Lipolysis & Optimized Weight-Management
Ready to jump feet-first into the nitty-gritty? Here’s a breakdown of how AOD9604 could fit into non-anabolic fat-loss research:
1. Mechanism Overview:
Derived from the C-terminal sequence of hGH, AOD9604 mimics the fat-reducing action of growth hormone but skips the muscle-building scene. Its folding and structure ensure targeted receptor activation linked to lipolysis.
2. Weight Loss in Preclinical Models:
Studies in animal models reveal meaningful reductions in fat mass, with little or no effect on lean body mass. Researchers observed improvement in fat percentage, particularly with chronic administration. In one study, chronic treatment with AOD9604 increased fat oxidation rates significantly compared to saline controls (Heffernan et al., 2001).
3. Metabolic Markers:
Some evidence links AOD9604 research to improved insulin sensitivity, reduced blood triglycerides, and anti-inflammatory phenomena, although results are preliminary and need extensive validation.
4. Comparison with Other Peptides:
Unlike anabolic agents like CJC-1295 or GHRP-2, AOD9604 brings the heat to the fat-loss party without crowding the muscle-building dance floor. If your research pivots on non-anabolic weight-management, this is the peptide to watch.
Curious how these stack up? Explore CJC-1295 or GHRP-2 for a robust comparison. But don’t forget: All our products are for research use only.
FAQ: Burning Questions on AOD9604, Fat-Loss & Non-Anabolic Metabolism
1. What is AOD9604, and how is it different from regular hGH fragments?
AOD9604 is a synthetic fragment (176-191) of human growth hormone, optimized for fat-loss through targeted lipolysis, without the muscle-building effects or hormonal impacts of full hGH peptides.
2. Does AOD9604 promote muscle growth?
No. It’s strictly non-anabolic. It zeroes in on fat metabolism and weight-management with no direct impact on lean muscle.
3. What’s the mechanism of action for AOD9604 in research models?
AOD9604 enhances lipolysis in adipose tissue by mimicking certain fat-burning actions of hGH but does not activate the broader anabolic or IGF-1 pathways.
4. Can AOD9604 improve other markers of metabolism besides fat-loss?
Studies suggest potential benefits for insulin sensitivity and lipid profiles, but these findings are still in early research stages.
5. How does AOD9604 compare to traditional fat-loss agents?
Unlike stimulants or appetite suppressants, AOD9604 works directly on fat tissue with minimal central side effects, offering a targeted, non-anabolic approach.
6. Are there any surprising side effects?
In human safety trials involving approximately 900 subjects, AOD9604 showed a tolerability profile indistinguishable from placebo. Of course, all products are not for use in humans or animals—strictly research only.
7. What makes AOD9604 a promising tool for metabolic research?
Its focused action on fat tissue, non-anabolic profile, and minimal systemic effects create a unique research niche.
8. Can AOD9604 be stacked with other research peptides?
Absolutely—pairing with compounds that influence other aspects of metabolism can help researchers model multi-pronged weight-management strategies.
9. Where do I find AOD9604 for research?
We offer AOD9604 for research purposes only here at OathPeptides.com.
10. What are the main benefits for experimental weight-management?
Precision fat-loss, study of non-anabolic metabolism, and lack of hormonal disruption are key perks.
11. Is there human data on AOD9604?
Yes—early-phase clinical trial data across six placebo-controlled studies exists, demonstrating safety and tolerability. However, the peptide has not been approved for human or animal use. All findings should be interpreted strictly in a research context.
Wrapping It Up: The Future of Fat-Loss and Non-Anabolic Metabolism
In the wild world of metabolism research, AOD9604 is generating serious buzz. Its unique focus on fat-loss, targeted lipolysis, and non-anabolic profile sets it apart from traditional peptides and promises new insights for metabolic science and weight-management.
Curious to join the next wave of discovery? Grab AOD9604 and other high-purity peptides (like hGH Fragment 176-191) for your next research project at OathPeptides.com. Remember, every product is for research use only—please do not use it in humans or animals.
—
$99.99Original price was: $99.99.$95.00Current price is: $95.00.References
1. Ng FM, Sun J, Sharma L, Libinaka R, Jiang WJ, Gianello R. “Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.” Hormone Research. 2000;53(6):274-278. PubMed
2. Heffernan MA, Thorburn AW, Fam B, Summers R, Conway-Campbell B, Waters MJ, Ng FM. “Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.” International Journal of Obesity. 2001;25(10):1442-1449. PubMed
3. Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM. “The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.” Endocrinology. 2001;142(12):5182-5189. PubMed
4. Stier H, Vos E, Kenley D. “Safety and tolerability of the hexadecapeptide AOD9604 in humans.” Journal of Endocrinology and Metabolism. 2013;3(1-2):7-15. Full Text
5. More MI, Kenley D. “Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health.” Journal of Endocrinology and Metabolism. 2014;4(3):59-69. Full Text
6. Kwon DR, Park GY. “Effect of intra-articular injection of AOD9604 with or without hyaluronic acid in rabbit osteoarthritis model.” Annals of Clinical and Laboratory Science. 2015;45(4):426-432. PubMed
7. Liao HJ, Chen HT, Chang CH. “Peptides for targeting chondrogenic induction and cartilage regeneration in osteoarthritis.” Cartilage. 2024;15(3):303-318. PubMed
For detailed product info, visit AOD9604 Peptide Research.
All statements herein refer to laboratory research, not clinical or personal use. Oath Research peptides are sold strictly for research—never for human or animal use.
Related Posts
Melanotan I: Stunning Tanning Peptide or Risky Hype?
Curious about getting that bronzed look without basking in the sun? Melanotan I, a tanning peptide making waves in research circles, promises a stunning tan— but does this shortcut to sun-kissed skin come with hidden risks?
D-Peptides Research: Protease Resistance & Stability Science
D‑peptides stand out for their exclusive protease resistance, giving them unmatched stability that keeps them intact and effective longer than natural peptides. This unique trait makes D‑peptides a game-changer in research and therapeutic fields where durability is key.
Selank and Semax: Tuftsin-Derived Peptides and BDNF Expression in Rodent Studies
Selank and Semax, synthetic heptapeptides derived from tuftsin and ACTH(4-10) respectively, modulate BDNF expression through distinct yet overlapping neurotrophic signaling cascades. This review compares their preclinical pharmacology, gene expression profiles, and receptor interactions in rodent models.
gh-secretagogue Stack: Can Negative Synergy Limit gh-pulse Recovery?
Curious about whether your gh-secretagogue stack could be holding back gh-pulse recovery or lean-mass gains? Dive in as we unravel how synergy—both good and bad—might influence your stacking strategies in the pursuit of optimal research outcomes.